Skip to content

Study the effect of pulmonary rehabilitation on the respiratory system of severe patients and the value of ultrasound in guiding pulmonary rehabilitation

Study the effect of pulmonary rehabilitation on the respiratory system of severe patients and the value of ultrasound in guiding pulmonary rehabilitation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048723
Enrollment
Unknown
Registered
2021-07-13
Start date
2021-07-20
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary rehabilitation therapy

Interventions

Observation group:Pulmonary rehabilitation therapy
Control group:No

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of the 2018 Chinese Adult Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia Diagnosis and Treatment Guidelines, and the sputum bacterial culture and drug susceptibility test results are determined to be multi-drug resistant; 2. Age 18 to 75 years old; 3. The RASS sedation score of sedated patients is +2, +1, 0, -1, -2, -3; 4) Hemodynamically stable, mean arterial pressure: 60-110 mmHg; 5. The vital signs are stable; 6. Respiration-related indicators are stable: SPO2>90%, respiratory rate <40 beats/min, positive end-expiratory pressure <10 cmH2O for those on a ventilator; 7. Sign the informed consent; 8. Patients with central nervous system disease or injury.

Exclusion criteria

Exclusion criteria: 1. High-risk groups who are judged by specialists to be unable to participate in pulmonary rehabilitation intervention and ultrasound examination; 2. People with autoimmune disease, heart disease, liver disease, kidney disease, skin disease, blood disease and active tuberculosis; 3. Myocardial infarction, massive hemoptysis, unstable angina pectoris occurred within 2 weeks; 4. Pregnant and lactating women; 5. Intracranial pressure >=200mmH2O.

Design outcomes

Primary

MeasureTime frame
Clinical pulmonary infection score;

Countries

China

Contacts

Public ContactShi Zhange, Sun Yang

Xiangya Hospital of Central South University

372810727@qq.com+86 15802624956

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026